Active Ingredient(s):Ansuvimab-zykl FDA Approved: * December 21, 2020 Pharm Company: *RIDGEBACK BIOTHERAPEUTICS Category:Antiviral
Ansuvimab, sold under the brand name Ebanga, is a monoclonal antibody medication for the treatment of Zaire ebolavirus (Ebolavirus) infection.
The most common symptoms include fever, tachycardia (fast heart rate), diarrhea, vomiting, hypotension (low blood pressure), tachypnea (fast breathing) and chills; however, these are also common symptoms of Ebolavirus infection.
Ansuvimab was approved for medical use in the United States in Decem...
* May have multiple approval dates, manufacturers, or labelers.